Investing.com - Avita Medical (NASDAQ:RCEL) reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Avita Medical announced earnings per share of $-0.38 on revenue of $7.54M. Analysts polled by Investing.com anticipated EPS of $-0.356 on revenue of $7.2M.
Avita Medical shares are down 52.92% from the beginning of the year, still down 74.92% from its 52 week high of $22.49 set on June 25, 2021. They are under-performing the Nasdaq which is down 27.32% from the start of the year.
Avita Medical follows other major Healthcare sector earnings this month
Avita Medical's report follows an earnings beat by J&J on April 19, who reported EPS of $2.67 on revenue of $23.43B, compared to forecasts EPS of $2.59 on revenue of $23.62B.
UnitedHealth had beat expectations on April 14 with first quarter EPS of $5.49 on revenue of $80.15B, compared to forecast for EPS of $5.36 on revenue of $78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar